Table 3 |
||
|
Pathway analysis of 2223 significant genes using a Fisher's Exact Test identified the listed pathways (p < 0.05) that might be related to human liver cancer. |
||
|
Pathways |
The number of significant genes found in a pathway divided by the genes from the chip found in the same pathway |
P value |
|
|
||
|
Apoptosis |
||
|
TGF Beta Induced apoptosis |
18/35 |
0.00055 |
|
Cell cycle |
||
|
P53 signaling pathway |
11/21 |
0.0079 |
|
Regulation of P27 during cell cycle progression |
6/8 |
0.0036 |
|
Influence of Ras and Rho Protein on G1 to S transition |
9/12 |
0.00031 |
|
ECM and Integrin mediated signaling pathway |
6/10 |
0.017 |
|
Rb signaling pathway |
10/13 |
0.0001 |
|
Cyclin mediated Pathway |
13/19 |
0.000062 |
|
G1-S checkpoint |
15/21 |
0.0000072 |
|
Growth and differentiation |
||
|
Insulin signaling pathway |
8/16 |
0.035 |
|
TGF beta signaling pathway |
7/13 |
0.021 |
|
Amino Acid/Metabolic pathway |
||
|
Methionine Metabolism |
4/5 |
0.014 |
|
Other Signaling pathways |
||
|
PKC-mediated pathway |
8/13 |
0.0047 |
|
Heregulin signaling pathway |
14/34 |
0.027 |
|
AR Mediated Signaling Pathway |
9/20 |
0.038 |
|
Apigenin Signaling Pathway |
6/9 |
0.0085 |
|
|
||
|
Fang et al. BMC Bioinformatics 2005 6(Suppl 2):S6 doi:10.1186/1471-2105-6-S2-S6 |
||